TL;DR
Get beauty and skincare favorites delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Global Cosmetics News’ Week 42 review reports major beauty-sector deals, sales updates and retail expansion, alongside manufacturing investment and digital initiatives. It also highlights legal disputes, trade delays and consumer-protection scrutiny; several reported plans and negotiations may still change.
Global Cosmetics News’ Week 42 review brings together a busy stretch for the cosmetics and personal care sector, including Galderma’s reported agreement to acquire ZO Skin Health for US$1.5 billion, LVMH sales growth and retail expansion across Asia and India. The roundup also records mounting pressures from legal disputes, customs delays and calls for stronger consumer protection, offering a snapshot of how companies are balancing growth with operational and reputational risks.
The corporate moves ranged from acquisitions to disposals. Galderma agreed to buy physician-dispensed skincare brand ZO Skin Health for US$1.5 billion, according to the review. Separately, Bogart sold its 47-store Israeli cosmetics retail subsidiary for €5.8 million. The European Union approved Kimberly-Clark’s US$40 billion acquisition of Kenvue after a divestment agreement. The roundup also notes that Amazon entered discussions to acquire AI start-up Decart for about US$7 billion, a technology-sector deal rather than a cosmetics transaction.
Financial updates showed different sources of growth across beauty and retail. LVMH reported higher third-quarter sales across its beauty operations and Sephora network. Shein said UK sales rose 26 percent to £2.58 billion, overtaking Asos, while Beauty Tech Group executives sold £6 million in shares after the company’s strong initial public offering performance. e.l.f. Beauty said it planned to put a US$50 million tariff refund toward pricing and marketing initiatives.
Companies also pushed into new markets and channels. CJ Olive Young expanded K-beauty distribution through Sephora stores in Southeast Asia and Hong Kong; Nykaa and L’Oréal supported a new Kiehl’s skincare launch in India; and Kiko Milano set out plans to double its Indian store footprint by the end of 2026. In the United States, Bluemercury relaunched its Lune+Aster makeup brand. Other developments included Estée Lauder’s €5.7 million manufacturing investment in Belgium, e.l.f. Cosmetics’ virtual experience on ZEPETO, and L’Oréal Travel Retail’s sustainability partnership with Avolta.
Expansion Meets Rising Business Risks
The week’s developments show how beauty companies are pursuing growth through portfolio changes, international distribution and investment while facing constraints that cross borders and business functions. A large acquisition can reshape brand ownership and distribution, while retail expansion in India and Asia gives companies access to new customers. The review, however, does not provide transaction closing dates or detailed forecasts for those plans.
At the same time, the reported Shiseido-Shein dispute, customs delays affecting French exporters in China and calls for tighter UK aesthetics oversight point to risks beyond sales performance. Companies operating across markets may need to manage intellectual-property questions, trade frictions and consumer standards alongside investment and marketing decisions. These are reported developments, not evidence that any allegation has been legally established.
As an affiliate, we earn on qualifying purchases.
Deals, Retail and Policy Pressures
The review groups activity across several parts of the industry rather than describing a single event. Corporate transactions and restructuring sat alongside quarterly sales, store expansion, product launches and supply-chain projects. The mix reflects a sector where brand ownership, retail access and manufacturing capacity are closely connected, but the source offers a weekly roundup rather than a full account of each company’s results or strategy.
Some items also concern wider business conditions. The EU’s approval of Kimberly-Clark’s Kenvue acquisition followed a divestment agreement, while French cosmetics exporters were reported to be experiencing customs delays in China amid trade tensions. The review says Kering and LVMH strengthened their model protection charter, but does not detail the updated standards. Superdrug called for stronger regulation of the UK aesthetics industry, adding a consumer-protection issue to a week otherwise dominated by commercial expansion.
Deal Status and Disputes Still Open
The roundup does not specify whether the Galderma-ZO Skin Health agreement has closed, what conditions remain, or when ownership would change. It also gives no further detail on the divestment tied to EU approval of the Kimberly-Clark-Kenvue deal. Amazon’s reported discussions with Decart are not described as a signed agreement, and their status is unclear.
Legal and regulatory details are limited. Shiseido filed a €2.6 million lawsuit against Shein over alleged unauthorised cosmetics sales; the allegation is not established as fact in the source, and the case outcome is not reported. The roundup does not explain the scale or duration of China customs delays, the specific regulatory changes Superdrug sought, or how the updated model protection standards will be applied.
Closings, Rollouts and Further Detail
Readers will need follow-up reporting to learn whether the announced transactions close, when they take effect and what they mean for the brands involved. The next stated retail milestone is Kiko Milano’s plan to double its Indian footprint by the end of 2026. The review does not provide launch dates for the other distribution initiatives or further milestones for the manufacturing and sustainability projects.
Updates may also clarify the progress of Shiseido’s case against Shein, the extent of customs delays for French exporters and whether UK aesthetics regulation changes. The AI-related marketing discussion involving Hunter and Rhode Beauty was described as an AI-generated concept raising questions about unofficial brand collaborations; the source does not establish that it was an authorised partnership. No additional company or regulator statements are supplied in the review.
Key Questions
What was the main development in the Week 42 review?
The review covered several developments rather than one announcement, including Galderma’s reported US$1.5 billion agreement to acquire ZO Skin Health, sales updates, international retail expansion and industry disputes.
Did Galderma complete its acquisition of ZO Skin Health?
The source says Galderma agreed to acquire the brand for US$1.5 billion. It does not say the transaction has closed or provide a closing date.
What legal issue involving Shiseido and Shein was reported?
Shiseido filed a €2.6 million lawsuit against Shein over alleged unauthorised cosmetics sales. The source does not report a court decision, and the allegation should not be treated as proven.
Which retail expansions were highlighted?
The review reported CJ Olive Young distribution through Sephora in Southeast Asia and Hong Kong, a Kiehl’s launch in India through Nykaa and L’Oréal, and Kiko Milano’s plan to double its Indian retail footprint by the end of 2026.
What remains uncertain about the reported business developments?
The source does not give closing timelines for key deals, details of the customs delays in China, the outcome of the Shiseido-Shein case or the status of Amazon’s reported discussions with Decart.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
